Drug Information

Drug General Information
Drug ID
D03QMY
Former ID
DNCL002722
Drug Name
IDM-2101
Drug Type
Vaccine
Indication Colorectal cancer [ICD9: 153, 154; ICD10:C18-C21] Phase 2 [529705]
Company
Biotech Synergy
Target and Pathway
Target(s) Carcinoembryonic antigen-related cell adhesion molecule 5 Target Info [529705]
Melanoma-associated antigen 3 Target Info [529705]
NetPath Pathway TGF_beta_Receptor Signaling Pathway
References
Ref 529705Induction of immune responses and clinical efficacy in a phase II trial of IDM-2101, a 10-epitope cytotoxic T-lymphocyte vaccine, in metastatic non-small-cell lung cancer. J Clin Oncol. 2008 Sep 20;26(27):4418-25.
Ref 529705Induction of immune responses and clinical efficacy in a phase II trial of IDM-2101, a 10-epitope cytotoxic T-lymphocyte vaccine, in metastatic non-small-cell lung cancer. J Clin Oncol. 2008 Sep 20;26(27):4418-25.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.